Bio-Techne Corp

TECH

Company Profile

  • Business description

    Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

  • Contact

    614 McKinley Place N.E.
    MinneapolisMN55413
    USA

    T: +1 612 379-8854

    https://www.bio-techne.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    3,100

Stocks News & Analysis

stocks

Fair value upgrade for this ASX income player

Headwinds in listed energy stocks likely to have passed
stocks

The SpaceX IPO and the Elon Musk factor

Potential investors should remember that the company’s controlling shareholder can move markets with a few words.
stocks

The ASX’s most shorted stocks in 2026

What we can and can’t learn from the top 20 most shorted ASX shares.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,683.9011.500.13%
CAC 407,834.8662.410.80%
DAX 4022,778.98216.100.96%
Dow JONES (US)45,216.1449.500.11%
FTSE 10010,226.7698.800.98%
HKSE24,788.1437.350.15%
NASDAQ20,794.64153.72-0.73%
Nikkei 22551,063.72822.13-1.58%
NZX 50 Index12,912.11163.191.28%
S&P 5006,343.7225.13-0.39%
S&P/ASX 2008,481.804.600.05%
SSE Composite Index3,891.8631.43-0.80%

Market Movers